EUVIMEDEUVIMED entdecken
Crossref

https://www.iosrjournals.org/iosr-jdms/papers/Vol25-issue6/Ser-2/B2506020406.pdf

Dr.Mohammadhusen M. Sheliya, Dr.Jyoti Mannari, Dr.Kushal Pujara

IOSR Journal of Dental and Medical Sciences · 2026-06 · 25 (6) · 07-09

DOI: 10.9790/0853-2506020709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-06. Verfasst von Dr.Mohammadhusen M. Sheliya und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart Failure with Reduced Ejection Fraction (HFrEF) poses significant morbidity and mortality risks globally. Goal-Directed Medical Therapy (GDMT) improves outcomes but is often underutilized due to poor medication adherence.

Aim

To evaluate the impact of GDMT on clinical outcomes such as quality of life, morbidity, and hospitalizations in HFrEF patients, and to assess the level and predictors of medication adherence.

Methods

A cross-sectional study was conducted at Shree Krishna Hospital involving 100 adult patients with HFrEF. Adherence was measured using the Morisky Green Levine Scale. Quality of life (QoL) was evaluated utilizing the Minnesota Living with Heart Failure Questionnaire (MLHFQ) at baseline and a 6-month followup. Descriptive statistics, Chi-square tests, and logistic regression were used to analyze the data.

Results

The cohort (mean age primarily 61–70 years; 64% male) demonstrated low overall adherence: 6% complete, 54% medium, and 40% low adherence. Despite this, 78% of patients were on some form of GDMT. At 6 months, patients receiving GDMT had significantly better QoL outcomes compared to non-recipients (p=0.006). Education level emerged as a strong, statistically significant predictor of higher medication adherence.

Conclusion

While GDMT profoundly improves Quality of Life for HFrEF patients, medication adherence remains a pervasive challenge. Tailored, patient-centered interventions focusing on education and continuous monitoring are essential to optimize therapeutic benefits.

Zitieren

APA

Sheliya, D. M., Mannari, D., & Pujara, D. (2026). https://www.iosrjournals.org/iosr-jdms/papers/Vol25-issue6/Ser-2/B2506020406.pdf. IOSR Journal of Dental and Medical Sciences, 25(6), 07-09. https://doi.org/10.9790/0853-2506020709

Vancouver

Sheliya DM, Mannari D, Pujara D. https://www.iosrjournals.org/iosr-jdms/papers/Vol25-issue6/Ser-2/B2506020406.pdf. IOSR Journal of Dental and Medical Sciences. 2026;25(6):07-09. doi:10.9790/0853-2506020709

BibTeX
@article{Sheliya2026,
  author = {Sheliya, Dr.Mohammadhusen M. and Mannari, Dr.Jyoti and Pujara, Dr.Kushal},
  title = {https://www.iosrjournals.org/iosr-jdms/papers/Vol25-issue6/Ser-2/B2506020406.pdf},
  journal = {IOSR Journal of Dental and Medical Sciences},
  year = {2026},
  volume = {25},
  number = {6},
  pages = {07--09},
  doi = {10.9790/0853-2506020709}
}
Kostenlos starten →